ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Evonik And Akzo Eye End To Mercury Cl2

by Michael McCoy
July 28, 2014 | APPEARED IN VOLUME 92, ISSUE 30

Evonik Industries and AkzoNobel are in talks about building a membrane-based chlor-alkali facility at Akzo’s site in Ibbenbüren, Germany. To produce chlorine and potassium hydroxide, the plant will replace similar mercury-cell-based operations at the site. The partners expect the facility to open in the third quarter of 2017 in advance of a new law that requires the end of mercury-based production by 2018. Akzo will market chlorine and hydrogen. Evonik will market potassium hydroxide, converting some to potassium carbonate at its plant in Lülsdorf, Germany.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment